poisar

Stocks · News reference

Barclays Maintains Underweight on Clarivate, Lowers Price Target to $2

BenzingaJul 30, 2026, 10:34 AMBenzinga Newsdesk

Barclays analyst Manav Patnaik maintains Clarivate (NYSE:CLVT) with a Underweight and lowers the price target from $2.5 to $2.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 30, 2026, 10:34 AM
Checked
Jul 30, 2026, 10:33 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading